Novartis's Scemblix Gets FDA Approval for Two Indications in Chronic Myeloid Leukemia

By Cristina Roca


Novartis AG said late Friday that the U.S. Food & Drug Administration has approved Scemblix for two indications in chronic myeloid leukemia.

The Swiss... | November 1, 2021

Related Keywords

Switzerland ,Swiss ,Cristina Roca ,Us Food Drug Administration , ,Drug Administration ,Dow Jones ,Novartis Ag Stock Exchange ,News ,Information ,Press Release ,Y ,Ristina ,Moca ,Novartis ,G ,Aid ,Gate ,Friday ,Hat ,The ,Wood ,Drug ,Administration ,Gas ,Approved ,Scemblix ,Or ,Two ,Indications ,N ,Hronic ,Amyeloid ,He Novn Ch0012005267 ,